Comparison of Metformin and Myoinositol on Clinical, Hormonal and Metabolic Profile of Patients with Polycystic Ovarian Syndrome: An Open-label Randomised Clinical Trial

Introduction: The prevalence of Polycystic Ovarian Syndrome (PCOS), one of the common endocrine disorders among women of reproductive age, varies from 2.2% to 26% globally. The treatment for PCOS aims to reduce Body Mass Index (BMI), improve underlying hormonal disturbances, prevent future repr...

Full description

Bibliographic Details
Main Authors: Prithiv Raj, Sunita Samal, Shanmugapriya Chandrasekaran, Karthiga Prabhu, Maitrayee Sen
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2024-01-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/18978/67746_CE[Ra1]_F(SS)_QC_PAT(SD_RN_IS)_PF1(RI_DK)_PFA(RI_KM)_PN(KM).pdf